Exclusive Content
Medicare Now Covers Obesity Drugs: Affordable GLP-1 Access Begins
In a landmark shift for American healthcare, Medicare has begun covering GLP-1 medications — including semaglutide (Wegovy) and tirzepatide(Zepbound) — for patients with obesity and related conditions,...
India’s CDSCO Bans Injectable Products From Being Marketed as Cosmetics
The Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, has issued a...
Sun Pharma Reports Strong Q4 with 26% Growth in Net Profit
Sun Pharmaceutical Industries Limited reported a strong fourth quarter for FY26, with consolidated net profit rising 26.2% year-on-year to ₹2,714 crore. Revenue for the quarter...
West Bengal Healthcare Gets Major Boost as Centre Reviews Key Health Schemes
Union Health Minister Jagat Prakash Nadda held a virtual review meeting with West Bengal officials to assess the state’s healthcare systems and discuss ways to strengthen...
J P Nadda Speaks on TB Prevention at Geneva Global Health Summit
India reinforced its commitment to tuberculosis prevention and stronger lung health screening as Union Health Minister Jagat Prakash Nadda addressed a key side-event on “Ministerial Perspectives...
Dr. Reddy’s Launches Affordable Oral Diabetes Drug in India
Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...